Resources
The latest in biomarkers research, from development and diagnostics to precision medicine
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Biomarker Technologies
The Power of Real-World Data Analytics in Biomarker Discovery: A Game-Changer in Medical Research
Biomarker discovery in medical research traditionally relied on controlled trials. Now, Real-World Data Analytics offers a transformative approach, analyzing real-world patient data to identify new biomarkers and improve patient care.
Biomarker Technologies
Post-Event Proceedings – Biomarkers 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at Biomarkers 2023.
Biomarker Technologies
Exploring the Pivotal Role of Medical Imaging Technology in Biomarker Discovery
Biomarker Technologies
Biomarker Strategies for Monitoring the Tumour Microenvironment
Here, we discuss the development and application of multiplex immunofluorescence-based biomarker strategies to study the tumour microenvironment in lymphoma patients, exploring how these approaches can help to identify immune cell interactions.
Biomarker Technologies
Interview with Simon Gao, Clinical Imaging Scientist at Genentech
Simon Gao of Genentech discusses his background in clinical imaging and the impact that AI-based approaches may have on biomarker discovery.
Biomarker Technologies
Blood Markers of Brain Health: The Simoa® Platform—Measuring CNS biomarkers in serum and plasma with ultrasensitivity
With a sensitivity many times greater than traditional ELISA methods, the Simoa® platform can measure brain biomarkers in blood, offering you another dimension of data from a readily available, non-invasive source.
Biomarker Technologies
Lung Cancer Patient Response to Immunotherapy Could be Predicted Through AI-Calculated Biomarker
Breakthroughs in the use of AI for biomarker prediction and validation of efficacy could shape future treatments for immunotherapies. In this case study, we look at its applications in validating lung cancer patient responses to treatment.
Biomarker Technologies
FMP Olink Services - Biomarker Solutions from Discovery to Clinical Qualification
Biomarker Technologies
Gyros Protein Technologies - Extended Sensitivity for PK and Biomarker Analysis
Biomarker Technologies
Merck Millipore - Multiplexed Evaluation of Soluble Immune Checkpoint Molecules
Biomarker Technologies
MILLIPLEX Human Cytokine Panel: A Lot to Lot Consistency of Cytokine Measurement
Biomarker Technologies
Breath Biopsy Omni For Comprehensive & Reliable Detection Of VOC Biomarkers In Breath
On-Demand Webinar featuring Dr Elizabeth Crone, Business Development Manager at Owlstone & Dr Hsuan (Tina) Chou, Biomarker Scientist at Owlstone
Biomarker Technologies
Are Neuroimmune Proteins the Key to Neurodegenerative Disease Diagnosis?
Unique neuroinflammatory signatures and pathways present in tauopathies could provide greater insight into distinct mechanisms of disease.
Biomarker Technologies
Biomarker Testing Consolidation and Implementation Using Multiplex Immunofluorescence
Multiplex immunofluorescence is gaining prevalence in oncology diagnostics; what makes it so effective, and how is it being brought into the clinic?
Biomarker Technologies
GOAL: A Collaborative Approach to Next Generation Sequencing in Oncology and Beyond
The Genomics Organisation for Academic Laboratories – known also to the world as GOAL – is a collaborative project set up by a group of academic centres across the United States to facilitate affordable next generation sequencing. The long-term target is to expand patient access to personalised genomic testing, as well as future biomarker discovery.
Biomarker Technologies
Enabling Precision Oncology with Tumour Profiling Solutions
Erin Newburn, Senior Director, Field Applications Scientist at Personalis, Inc. showcases the Personalis NeXT Platform ®, a tumour profiling solution for both tissue and liquid biopsies at Biomarkers UK 2022.
Biomarker Technologies
Unlocking the Potential of Spatial Multi-Omics and Cytometry
Senior representatives from Ultivue, Genentech, and GSK discuss the current trends and opportunities in enabling the future of multi-omics-based analysis.
Biomarker Technologies
Spatial Biomarkers & Multiplexed Immunofluorescence in Immuno-Oncology
Yu Liang, Director of Clinical Biomarkers at Compugen, leads a discussion on ‘Spatial Biomarkers & Multiplexed Immunofluorescence in Immuno-Oncology.’
Biomarker Technologies
Implementing Flow Cytometry Assays In Biomarker Research
Oxford Global’s Discussion Groups provide a focused networking opportunity for a select group of like-minded experts on a monthly basis. Our first Biomarkers Discussion Group addressing ‘Implementing Flow Cytometry Assays In Biomarker Research’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things biomarkers